Genomenon Inc.
PrivateLast Round
Early Funding
Jul 15, 2026
Total Funding Raised
$33.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomenon Inc. operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was a Series B round in March 2022.
Genomenon Inc. is an AI-driven genomics company that provides software, data, and services for genomic information analysis to support clinical and pharmaceutical organizations.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting, Freemium, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomenon Inc. Comparables
Compare Genomenon Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saphetor | 85% | |
| SeqOne | 81% | |
| Geneyx | 80% |
For institutional investors. Book with your work email.
Genomenon Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 15, 2026 | ||||
| Early Funding | May 1, 2024 | ||||
| Series B | Mar 10, 2022 | ||||
| Grant | Feb 15, 2022 | ||||
| Series A | Mar 16, 2021 | ||||
Seed | Jan 8, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genomenon Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invest Detroit | Seed |
| NIH RADx | Grant |
| Monroe-Brown Foundation | Seed |
| University of Michigan | Series B |
| Beringea | Series B |
| Ann Arbor SPARK | Series A, Series B, Seed |
| Michigan Investment in New Technology Startups | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Raised $6M in seed funding.
- Jan 22, 2026
Monthly visitors increased 45% MoM, reaching 32.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 7, 2026
GenomeWeb names Genomenon one of its Best Places to Work winners in the 51–100 employees category for the third consecutive year in Michigan on Oct 15th '26.
For institutional investors. Book with your work email.
Genomenon Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genomenon Inc.'s valuation, stock price, and market status.
Is Genomenon Inc. a public or private company?
Genomenon Inc. is a private company.
What is the current stock price of Genomenon Inc.?
Genomenon Inc. is a private company, so its shares have no public market price. Caplight tracks Genomenon Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genomenon Inc. worth (valuation)?
Valuation information for Genomenon Inc. is not publicly available.
Can I buy Genomenon Inc. stock?
Genomenon Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genomenon Inc.'s last funding round?
Genomenon Inc.'s most recent funding round was Early Funding on July 15, 2026.
Who are the main investors in Genomenon Inc.?
Key investors in Genomenon Inc. include Beringea, Spring Mountain Capital, BroadOak Capital Partners.
Will Genomenon Inc. IPO soon?
No public IPO plans have been announced for Genomenon Inc..
How can I track Genomenon Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Genomenon Inc.'s shares on secondary markets.